These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8877718)

  • 1. Purging of tumor cells from leukapheresis products: experimental and clinical aspects.
    Kvalheim G; Wang MY; Pharo A; Holte H; Jacobsen E; Beiske K; Kvaløy S; Smeland E; Funderud S; Fodstad O
    J Hematother; 1996 Aug; 5(4):427-36. PubMed ID: 8877718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
    Mohr M; Hilgenfeld E; Fietz T; Hoppe B; Koenigsmann M; Hoffmann M; Knauf WU; Cassens U; Sibrowski W; Kienast J; Thiel E; Berdel WE
    Clin Cancer Res; 1999 May; 5(5):1035-40. PubMed ID: 10353736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD34+ subset and tumor cell quantitation by flow cytometry--step toward quality assessment of autografts in B cell malignancies.
    Johnsen HE; Rasmussen T; Knudsen LM
    Vox Sang; 1998; 74 Suppl 2():477-82. PubMed ID: 9704485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo cytoreduction studies and cell sorting--enhanced tumor-cell detection in high-risk neuroblastoma patients: implications for leukapheresis strategies.
    Faulkner LB; Garaventa A; Paoli A; Tintori V; Tamburini A; Lacitignola L; Veltroni M; Lo Piccolo MS; Viscardi E; Milanaccio C; Tondo A; Spinelli S; Bernini G; De Bernardi B
    J Clin Oncol; 2000 Nov; 18(22):3829-36. PubMed ID: 11078496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.
    Mapara MY; Körner IJ; Hildebrandt M; Bargou R; Krahl D; Reichardt P; Dörken B
    Blood; 1997 Jan; 89(1):337-44. PubMed ID: 8978310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients: a pilot study.
    Mapara MY; Körner IJ; Lentzsch S; Krahl D; Reichardt P; Dörken B
    Exp Hematol; 1999 Jan; 27(1):169-75. PubMed ID: 9923456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decrease in tumor cell contamination and progenitor cell yield in leukapheresis products after consecutive cycles of chemotherapy for breast cancer treatment.
    Glück S; Ross AA; Layton TJ; Ostrander AB; Goldstein LC; Porter K; Ho AD
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):316-23. PubMed ID: 9502299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer.
    Preti RA; Lazarus HM; Winter J; Stadtmauer EA; Nadasi S; McMannis J; Karandish S; Jennis A; Goldberg SL; Pecora AL
    Cytotherapy; 2001; 3(2):85-95. PubMed ID: 12028831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device.
    van Heeckeren WJ; Vollweiler J; Fu P; Cooper BW; Meyerson H; Lazarus HM; Simic A; Laughlin MJ; Gerson SL; Koç ON
    Br J Haematol; 2006 Jan; 132(1):42-55. PubMed ID: 16371019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.
    Mohr M; Dalmis F; Hilgenfeld E; Oelmann E; Zühlsdorf M; Kratz-Albers K; Nolte A; Schmitmann C; Onaldi-Mohr D; Cassens U; Serve H; Sibrowski W; Kienast J; Berdel WE
    Clin Cancer Res; 2001 Jan; 7(1):51-7. PubMed ID: 11205918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients].
    Han X; Shi Y; Zhang W
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomagnetic purging of lymphoma cells from autografts.
    Kvalheim G; Holte H; Jakobsen E; Kvaloy S
    J Hematother; 1996 Oct; 5(5):561-2. PubMed ID: 8938530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large scale purification of human blood CD34+ cells from cryopreserved peripheral blood stem cells, using a nylon-fiber syringe system and immunomagnetic microspheres.
    Koizumi K; Nishio M; Endo T; Takashima H; Haseyama Y; Fujimoto K; Yamamoto S; Sato N; Ikebuchi K; Ikeda H; Koike T; Sawada K
    Bone Marrow Transplant; 2000 Oct; 26(7):787-93. PubMed ID: 11042662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells.
    Widmer L; Pichert G; Jost LM; Stahel RA
    Blood; 1996 Oct; 88(8):3166-75. PubMed ID: 8874217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for purging in autologous stem cell transplantation.
    Gulati SC; Acaba L
    J Hematother; 1993; 2(4):467-71. PubMed ID: 7916249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients.
    Lillo R; Ramírez M; Alvarez A; Santos S; García-Castro J; Fernández de Velasco J; Avilés MJ; Gómez-Pineda A; Díez JL; Balas A; Vicario JL; Bueren JA; García-Sánchez F
    Cancer Res; 2002 Sep; 62(17):5013-8. PubMed ID: 12208755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of CD34+ peripheral blood cells selected using a fully automated immunomagnetic system in patients with high-risk breast cancer: results of a prospective randomized multicenter clinical trial.
    Yanovich S; Mitsky P; Cornetta K; Maziarz RT; Rosenfeld C; Krause DS; Lotz JP; Bitran JD; Williams S; Preti R; Somlo G; Burtness B; Mills B
    Bone Marrow Transplant; 2000 Jun; 25(11):1165-74. PubMed ID: 10849529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer.
    Ho AD; Glück S; Germond C; Sinoff C; Dietz G; Maruyama M; Corringham RE
    Leukemia; 1993 Nov; 7(11):1738-46. PubMed ID: 7901454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.